Anti-VEGF Receptor 3 antibody and 4 more items

Epitomics Inc has been awarded a contract by the University of Virginia effective June 20, 2026, with a cumulative contract value of $2,103.75. The contract, identified as A207_PO-0404118-V3, is for the procurement of specialized research-grade antibodies and associated freight services. The University of Virginia serves as the contracting organization and buyer for this award in Virginia.

The deliverables under this contract comprise four distinct monoclonal antibody products and one freight fee line item. Epitomics Inc will supply 450 units of Anti-Vascular Endothelial Growth Factor Receptor 3 antibody, 569 units of Anti-Angiopoietin 2/Ang2 antibody (EPR2891(2)), 544 units of Anti-Vinculin antibody designated as a loading control, and 539 units of Anti-Von Willebrand Factor antibody (EPSISR15), with each antibody unit priced at $1.00. The contract also includes a freight fee charged at $1.00. These reagents are consistent with applications in vascular biology and immunological research, supporting the University of Virginia's research initiatives.